// COMPANY
Unlearn.AI
SECTOR NULLMENTIONS 1LAST SEEN JUNE 10, 2026
// OVERVIEW
Unlearn.AI is changing how we treat patients with medicines in trials by creating "digital twins" to test drugs in randomized controlled trials.
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·T1 Scout·JUNE 1, 2026
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.